Cooley advised Tocagen on its $97.8 million initial public offering of 9,775,000 shares of common stock. San Diego-based Tocagen, which trades on The NASDAQ Global Select…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
